gribio.com (GRI) - Yakuniy foyda

GRI (GRI Bio Inc) - kompaniyaning tovar belgisi

GRI Bio, Inc. (GRI) kompaniyasining GURU.Markets grafigidagi jamlangan foydasi daromad dinamikasini namoyish etadi, bunda -0.01 belgisi joriy holatni ko'rsatadi. GRI Bio, Inc. (GRI) aksiyalari tijorat mahsulotlarining yo'qligi va fibroz terapiyasining erta bosqichdagi sinovlari tufayli tebranishlarga moyil. Biznes hozirda rezervlarini NKT-hujayralar tadqiqotlariga sarflamoqda, biroq moslashuvchan ishlanmalar platformasi yuqori daromadlilikni va yangi formulalarning oson kengayishini ta'minlaydi.

GRI GRI Bio, Inc. Kompaniyaning sof foydasi (21.02.2024 - 29.10.2026)

GRI Bio (GRI) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Aksiya narxi GRI Bio Corporation|GRI - Konsensus maqsadli narx
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati GRI Bio Corporation|GRI - Korxona qiymati
- biznesning balans baholash tafsilotlari:
Aksiya hisobiga sof aktivlar GRI Bio|GRI - Kompaniyaning balans qiymati|Kapitallashuvning sof aktivlarga nisbati gribio.com|GRI - Kompaniyaning jami aktivlari
- qarz yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning xususiy kapitalga nisbati GRI Bio, Inc.|GRI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati GRI Bio Inc|GRI - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati GRI Bio Corporation|GRI - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz GRI Bio|Kritik likvidlik gribio.com
- foyda va multiplikatorlar bo'yicha ma'lumotlar:
GRI - Kompaniyaning sof foydasi
Kompaniyaning asosiy tahlili:GRI Bio Corporation
GRI Bio asosiy tovari

Ushbu ko'rsatkich operatsion daromadlar va xarajatlarni umumlashtirib, biznesning haqiqiy to'lov qobiliyatini baholash uchun barcha balans hisoboti bandlari prizmasi orqali sof moliyaviy natijani aks ettiradi. GRI Bio, Inc. (GRI) holatida, optimallashtirilgan boshqaruv samaradorligi va klinik sinovlarning optimizatsiyasi xarajatlarni minimallashtiradi, bu esa kompaniyaning foyda tarixi pul oqimi barqarorligini va yashirin qarz risklarining yo'qligini kuzatish imkonini beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

argenx BVBA (ARGX) - Sof foyda|Sof daromad BNTX|ABVX: Yakuniy foyda|Sof foyda ADMA|Sof moliyaviy natija Protagonist Therapeutics, Inc.|Kompaniyaning sof foydasi Immunovant Corp IMVT|KNSA - Sof daromad|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|CLDX (Celldex Therapeutics, Inc.) - Sof daromad|Aurinia Pharmaceuticals Inc (AUPH) - Sof foyda|Kompaniyaning sof foydasi BioCryst Pharmaceuticals Inc|Kompaniya foydasi VERA (Vera Corp)|Sof foyda DNTH|PHVS - Kompaniyaning sof daromadi|Sof foyda ABCL (AbCellera Biologics Inc)|Yillik sof foyda Tourmaline Bio Inc|PGEN - Kompaniyaning sof foydasi|Yakuniy foyda PHAR (Pharming Corp)|NKTR: Sof foyda|UPB - Sof moliyaviy natija|Sof daromad ZBIO|IMNM: Yakuniy foyda|Sof foyda GOSS|Kompaniyaning sof foydasi KALV (KalVista Corp)|Sof foyda SEPN (Septerna Inc)|Sof moliyaviy natija pieris.com (PVLA)|SVRA - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Rigel Pharma|ANAB (AnaptysBio Corp) - Sof daromad|Astria Corp - Yakuniy foyda|ENGN (enGene Holdings Inc.) - Sof foyda|rapt.com (RAPT) - Sof moliyaviy natija|Kompaniyaning sof foydasi Aerovate Therapeutics Inc (JBIO)|Aclaris Therapeutics Inc. - Kompaniya foydasi|Sof foyda KYTX (Kyverna)|TLSA - Sof daromad|CABA: Sof daromad|Sof moliyaviy natija ventyxbio.com VTYX|THTX: Sof foyda|Yillik sof foyda Avalo Therapeutics, Inc. AVTX|Kompaniyaning sof foydasi Eledon|AGEN: Yakuniy foyda|Sof foyda CLYM|Sof moliyaviy natija zurabio.com|Kompaniyaning sof foydasi aTyr Pharma ATYR|ADAG (Adagene Inc) - Soliqdan keyingi foyda|Ikena Oncology, Inc. - Sof foyda|Yakuniy foyda STTK (Shattuck Labs, Inc.)|EQ: Sof foyda|Connect Biopharma Holdings Limited (CNTB) - Sof foyda|Kompaniyaning sof foydasi Immunic Therapeutics|ATRA: Yakuniy foyda|Kompaniyaning sof foydasi InflaRx N.V. (IFRX)|Sof daromad X4 Pharmaceuticals, Inc XFOR|Sof foyda ACET (Adicet Bio, Inc.)|Sof foyda Celularity Inc CELU|INMB: Sof daromad|Yakuniy foyda BRNS (Barinthus Biotherapeutics PLC)|KZR: Sof foyda|SABS - Sof moliyaviy natija|Kompaniyaning sof foydasi Akari Therapeutics|Sof daromad Enlivex Therapeutics, Ltd. (ENLV)|Kompaniyaning sof foydasi Q32 Bio Inc. (QTTB)|Sof daromad GeoVax Labs GOVX|Edesa - Sof daromad|Sof foyda iBio Corporation IBIO|CARM - Kompaniyaning sof foydasi|XTLB (xtlbio.com) - Kompaniya foydasi|BOLT: Sof foyda|Kompaniyaning sof daromadi HCW Biologics (HCWB)|APVO (Aptevo Therapeutics, Inc.) - Sof foyda|AIM - Yillik sof foyda|Kompaniyaning sof foydasi Aditxt (ADTX)|XRTX (xortx.com) - Yakuniy foyda|Sof foyda HIND (Vyome Holdings)|Sof moliyaviy natija Revelation Biosciences Inc (REVB)|INDP: Sof daromad|Yakuniy foyda SCNI (BiondVax Pharmaceuticals)|CALI: Sof foyda|AFMD (Affimed N.V.) - Kompaniyaning sof foydasi|ALLK (Allakos Inc) - Sof foyda|HOOKIPA (HOOK) - Sof moliyaviy natija|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|ITOS - Kompaniyaning sof daromadi|Ocean Biomedical, Inc. - Sof daromad|Yakuniy foyda TCBP|Third Harmonic Bio, Inc. - Sof foyda